Microfluidics for Pharmaceutical Applications

Topic Information

Dear Colleagues,

In this topic, we aim to draw the interest of scientists in the microfluidic applications in the field of pharmacy. Microfluidics has been a renowned topic for the last three decades. The variety of applications of microfluidics, from biology to physics and chemistry, has been an interest of both academia and industry in recent years. In this topic, we aim to address the microfluidic applications in pharmacy. Authors can send their manuscripts to several high-impact journals included in this topic, such as Biosensors, Future Pharmacology, Micromachines, Pharmaceuticals, and Pharmaceutics. Here, we list some of the keywords ( but not limited to) which can be the main focus of the submitted manuscripts, namely: organ-on-chip, human-on-chip, drug delivery, nanotechnology, pharmacokinetics, drug screening, cancer, optical detections, diagnostics, point-of-care, bioanalysis, tissue chip, biochip, microfluidics, nanofluidics, microfabrication, nanofabrication, commercialization, rapid detection, early detection, personalized medicine, artificial intelligence, health intelligence, machine learning for health applications, data mining, and biosensors. As the topic editor of this Special Topic, we would like to thank the contributors for their valuable time and for submitting papers of high quality. If you have any research in this field that you would like to publish, please get in touch.

Dr. Trieu Nguyen
Prof. Dr. Dang Duong Bang
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Biosensors biosensors	5.743	5.6	2011	13.7 Days	2200 CHF	Submit
Future Pharmacology futurepharmacol	-	-	2021	19.7 Days	1000 CHF	Submit
Micromachines micromachines	3.523	4.5	2010	13.9 Days	2000 CHF	Submit
Pharmaceuticals pharmaceuticals	5.215	4.0	2004	15.6 Days	2200 CHF	Submit
Pharmaceutics pharmaceutics	6.525	6.0	2009	15.9 Days	2600 CHF	Submit

Published Papers (2 papers)

Order results

Content type Publication Date

Result details

Normal Extended Compact

Journals

All Biosensors Future Pharmacology Micromachines Pharmaceuticals Pharmaceutics

Show export options expand_more Show export options expand_less

Select all

Export citation of selected articles as:

Plain Text BibTeX BibTeX (without abstracts) Endnote Endnote (without abstracts) Tab-delimited RIS

Error

Oops... you haven't selected anything for export.

Ok

clear

get_app

subject

View online as:
Abstract Page
Full-Text HTML

Open AccessReview

Combining 3D Printing and Microfluidic Techniques: A Powerful Synergy for Nanomedicine

by

Federica Sommonte

,

Nunzio Denora

and

Dimitrios A. Lamprou

Pharmaceuticals 2023, 16(1), 69; https://doi.org/10.3390/ph16010069 - 01 Jan 2023

Cited by 1 | Viewed by 1065

Abstract

Nanomedicine has grown tremendously in recent years as a responsive strategy to find novel therapies for treating challenging pathological conditions. As a result, there is an urgent need to develop novel formulations capable of providing adequate therapeutic treatment while overcoming the limitations of [...] Read more.

Nanomedicine has grown tremendously in recent years as a responsive strategy to find novel therapies for treating challenging pathological conditions. As a result, there is an urgent need to develop novel formulations capable of providing adequate therapeutic treatment while overcoming the limitations of traditional protocols. Lately, microfluidic technology (MF) and additive manufacturing (AM) have both acquired popularity, bringing numerous benefits to a wide range of life science applications. There have been numerous benefits and drawbacks of MF and AM as distinct techniques, with case studies showing how the careful optimization of operational parameters enables them to overcome existing limitations. Therefore, the focus of this review was to highlight the potential of the synergy between MF and AM, emphasizing the significant benefits that this collaboration could entail. The combination of the techniques ensures the full customization of MF-based systems while remaining cost-effective and less time-consuming compared to classical approaches. Furthermore, MF and AM enable highly sustainable procedures suitable for industrial scale-out, leading to one of the most promising innovations of the near future. Full article

(This article belongs to the Topic Microfluidics for Pharmaceutical Applications)

►▼ Show Figures

Figure 1

attachment

Supplementary material:
Supplementary File 1 (ZIP, 1925 KiB)

get_app

subject

View online as:
Abstract Page
Full-Text HTML

Open AccessArticle

Flow Synthesis of L-α-Glycerylphosphorylcholine: Studies on Synthetic Routes Applicable to a Flow Reactor and Optimization of Reaction Conditions

by

Jihun Park

,

Seungjae Lee

,

Gyungtak Kim

,

Yashwardhan R. Malpani

,

Boyoung Y. Park

and

Ye-Jin Hwang

Pharmaceutics 2022, 14(11), 2480; https://doi.org/10.3390/pharmaceutics14112480 - 16 Nov 2022

Viewed by 678

Abstract

L-α-Glycerylphosphorylcholine (L-α-GPC) has mainly been produced by two methods: extraction from plants rich in phosphatidylcholine and chemical synthesis. However, production through extraction involves difficult processes, such as fermentation, extractions and ripening, and conventional chemical synthesis methods with high-cost reactants and a batch reactor. [...] Read more.

L-α-Glycerylphosphorylcholine (L-α-GPC) has mainly been produced by two methods: extraction from plants rich in phosphatidylcholine and chemical synthesis. However, production through extraction involves difficult processes, such as fermentation, extractions and ripening, and conventional chemical synthesis methods with high-cost reactants and a batch reactor. These methods are not ideal for large-quantity production. Thus, it is important to develop a simple production method of L-α-GPC, which is suitable for mass production without the need for expensive reactants. Here, we studied synthetic L-α-GPC methods that are applicable to a flow synthesis system, which can provide selectivity, reproducibility, scalability, and a high yield in short reaction time using inexpensive starting materials. We developed a two-step synthetic route to produce L-α-GPC, including the synthesis of phosphoryl choline using choline chloride and phosphoryl oxychloride (POCl₃) as a first step and synthesis of L-α-GPC by reacting phosphoryl choline with (R)-($-$)-3-chloro-1,2-propanediol (CPD) as a second step under basic conditions. Both steps were separately performed in a customized flow reactor, and reaction conditions were optimized. Finally, phosphoryl choline and L-α-GPC, the products first and second reactions, were successfully synthesized with high conversion yields of 97% and 79%, respectively. Full article

(This article belongs to the Topic Microfluidics for Pharmaceutical Applications)

►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less

Select all

Export citation of selected articles as:

Plain Text BibTeX BibTeX (without abstracts) Endnote Endnote (without abstracts) Tab-delimited RIS

 

Error

Oops... you haven't selected anything for export.

Ok

clear

Displaying articles 1-2